查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1388185

特種仿製藥市場、份額、規模、趨勢、行業分析報告：按類型、應用、最終用途、地區、細分市場預測，2023-2032 年

Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris市場研究的最新研究，到2032年，全球特種仿製藥市場預計將達到9,480.4億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

許多製藥、生物製藥和醫療器材公司都致力於透過併購擴大市場份額。 癌症、多發性硬化症 (MS) 和愛滋病毒等危及生命的疾病的盛行率在全球範圍內不斷增加，預計這將推動對特殊藥物的需求。 慢性病仍然是令人擔憂的一個主要原因，特別是在新興國家，慢性病是世衛組織六個區域中五個區域的主要原因。 愛滋病毒等傳染病在撒哈拉以南非洲仍然普遍存在，預計將繼續成為一個主要問題。 在預測期內，由於危及生命的疾病的高盛行率，特種藥品市場預計將快速成長。

2020年，COVID-19大流行對醫藥市場產生了重大影響，導致多家公司成長放緩、銷售額下降。 製造工廠面臨停工，臨床試驗和研究不得不停止，技術工人短缺。 Market Segmentation 就是其中之一，特種仿製藥業務下降了 6.6%，主要是由於大流行期間市場變化導致競爭加劇和產品結構變化。 然而，2021年，由於大規模疫苗接種、宅基地監管放寬以及治療慢性病的專科藥物需求增加，市場出現復甦跡象。

專科仿製藥市場報告亮點

在預測期內，注射劑細分市場預計將成為製藥業規模最大且成長最快的細分市場。 這是因為它具有持久的作用，並能很快被人體吸收，提高患者的依從性和接受度。 隨著新產品批准的增加和市場的擴大，該細分市場預計將快速成長。

2022年，發炎性疾病領域佔據最大的市場份額。 全世界患有類風濕性關節炎等發炎性疾病的患者數量正在增加。 根據全球 RA 網路的數據，大約有 3500 億人患有關節炎，NHS 報告稱，英國有超過 100 億人患有關節炎。 鑑於患病率的上升，醫療保健行業的主要參與者正在增加其在該領域的市場份額。

2022年，專業藥局領域佔據最大的市場份額。 由於分銷成本低且易於獲取藥品，主要仿製藥製造商和保險公司通常依賴專業藥房來分銷其產品。

美國食品藥物管理局 (FDA) 實施了監管政策來簡化新產品的批准。 為了確保公眾能夠獲得安全、有效和低成本的仿製藥，該部門推出了多項舉措，包括《哈奇-韋克斯曼法案》下的仿製藥使用者費用修正案 (GDUFA)。 因此，知名製造商不斷致力於將專門的仿製藥推向市場。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球專科仿製藥市場洞察

  • 特種仿製藥市場 - 最終用途概況
  • 專科仿製藥市場動態
    • 推動者和機會
      • 越來越重視併購，將其作為擴大特種仿製藥市場份額的手段
      • 特種藥物專利到期推動市場成長
    • 抑制因素和挑戰
      • 這些藥物的低利潤率和低認知度阻礙了市場成長
  • PESTEL 分析
  • 特殊仿製藥市場的最終用途趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球特種仿製藥市場（按類型）

  • 主要發現
  • 簡介
  • 注射
  • 口腔醫學
  • 其他

第 6 章全球特種仿製藥市場（按應用）

  • 主要發現
  • 簡介
  • 腫瘤
  • 發炎性疾病
  • 多發性硬化症
  • C型肝炎
  • 其他

第 7 章全球特種仿製藥市場，依最終用途劃分

  • 主要發現
  • 簡介
  • 專業藥房
  • 零售藥局
  • 醫院藥房

第 8 章全球特種仿製藥市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年專業仿製藥市場評估（按地區）
  • 特種仿製藥市場 - 北美
    • 北美：2019-2032 年特種仿製藥市場（按類型）
    • 北美：2019-2032 年特種仿製藥市場（依最終用途）
    • 北美：特種仿製藥市場，按應用劃分，2019-2032 年
    • 特種仿製藥市場 - 美國
    • 專業仿製藥市場 - 加拿大
  • 特種仿製藥市場 - 歐洲
    • 歐洲：2019-2032 年特種仿製藥市場（按類型）
    • 歐洲：特種仿製藥市場，依最終用途分類，2019-2032 年
    • 歐洲：特種仿製藥市場，按應用劃分，2019-2032 年
    • 專業仿製藥市場 - 英國
    • 專業仿製藥市場 - 法國
    • 專業仿製藥市場 - 德國
    • 專業仿製藥市場 - 義大利
    • 專業仿製藥市場 - 西班牙
    • 專業仿製藥市場 - 荷蘭
    • 特種仿製藥市場 - 俄羅斯
  • 專科仿製藥市場 - 亞太地區
    • 亞太地區：2019-2032 年特種仿製藥市場（按類型）
    • 亞太地區：2019-2032 年特種仿製藥市場（依最終用途）
    • 亞太地區：2019-2032 年特種仿製藥市場（按應用）
    • 專科仿製藥市場 - 中國
    • 專業仿製藥市場 - 印度
    • 專業仿製藥市場 - 馬來西亞
    • 專業仿製藥市場 - 日本
    • 專業仿製藥市場 - 印尼
    • 特種仿製藥市場－韓國
  • 特種仿製藥市場 - 中東和非洲
    • 中東和非洲：2019-2032 年特種仿製藥市場（按類型）
    • 中東和非洲：2019-2032 年特種仿製藥市場（依最終用途）
    • 中東和非洲：2019-2032 年特種仿製藥市場（按應用）
    • 特種仿製藥市場 - 沙烏地阿拉伯
    • 特種仿製藥市場 - 阿聯酋
    • 特種仿製藥市場 - 以色列
    • 特種仿製藥市場 - 南非
  • 特種仿製藥市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年特種仿製藥市場（按類型）
    • 拉丁美洲：以最終用途劃分的特種仿製藥市場，2019-2032 年
    • 拉丁美洲：2019-2032 年特種仿製藥市場（按應用劃分）
    • 專業仿製藥市場 - 墨西哥
    • 特種仿製藥市場 - 巴西
    • 專業仿製藥市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • Apotex Corp.
  • Bausch Health Companies Inc.（Valeant Pharmaceuticals International, Inc.）
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • Fresenius Kabi Brasil Ltda
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt
  • Novartis AG（Sandoz International GmbH）
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceuticals Industries Ltd
  • Viatris Inc.
Product Code: PM1215

The global specialty generics drugs market size is expected to reach USD 948.04 billion by 2032, according to a new study by Polaris market research. The report "Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Many pharmaceutical, biopharmaceutical, and medical device companies have been focusing on expanding their market presence by merging with or acquiring other companies. The prevalence of life-threatening diseases, such as cancer, Multiple Sclerosis (MS), and HIV, is increasing globally, which is expected to drive the demand for specialty medicines. Chronic diseases remain a major concern, particularly in emerging countries where they are the primary cause of mortality in five of the six WHO regions. Contagious diseases, such as HIV, are still widespread in Sub-Saharan Africa and are expected to continue to be a major issue. During the forecast period, the market for specialty medicines is expected to grow rapidly due to the high prevalence of life-threatening diseases.

In 2020, the COVID-19 pandemic had a significant impact on the pharmaceutical market, causing slower growth and a decline in net sales for several companies. Manufacturing plants had to face lockdown restrictions, clinical trials and studies had to be stopped, and there was a shortage of skilled labor. Mallinckrodt is one such company that experienced a -6.6% decline in its specialty generics segment, mainly due to increased competition and a change in product mix caused by market shifts during the pandemic. However, the market is showing signs of recovery in 2021, with mass vaccinations, easing of lockdown restrictions, and a growing demand for specialty medicines to treat chronic conditions.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Specialty generics drugs Market Report Highlights

During the forecast period, the Injectables segment is expected to be the largest and fastest-growing segment in the pharmaceutical industry. This is due to its ability to have long-lasting effects and quick absorption into the body, resulting in higher patient compliance and acceptance. With the increased approvals of new products and the expansion of the market, the segment is anticipated to grow rapidly.

In 2022, the largest market share was held by the segment of inflammatory conditions. The number of individuals with inflammatory conditions like rheumatoid arthritis is increasing globally. According to the Global RA Network, around 350 Billion people are living with arthritis, while the NHS has reported that over 10 Billion people in the UK are affected. In response to this rise in prevalence, major players in the healthcare industry are expanding their market share in this sector.

In 2022, the organic segment had the largest share. Organic bread improvers are made from organic ingredients and produced using organic farming methods. This means they are free from synthetic chemicals and GMOs. These organic improvers contain natural additives sourced from organic materials.

In 2022, the specialty pharmacy segment held the largest market share. Major generic manufacturers and insurance providers often rely on specialty pharmacies to distribute their products because of the low distribution costs and the easy accessibility of medicines offered by these pharmacies.

The US Food and Drug Administration (FDA) has implemented supportive regulatory policies to simplify the approval of new products. In order to make sure the public has access to safe and effective low-cost generic drugs, the agency has put several initiatives in place, including the Generic Drug User Fee Amendments (GDUFA) under the Hatch-Waxman Act. Consequently, prominent manufacturers are constantly working to introduce specialty generic drugs to the market.

The global key market players include: Apotex Corp., Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.), Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Fresenius Kabi Brasil Ltda, Hikma Pharmaceuticals PLC, Mallinckrodt, Novartis AG (Sandoz International GmbH)

Polaris market research has segmented the Speciality generics drugs market report based on type, application, end-user, and region:

Specialty generics drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Injectables
  • Oral Drugs
  • Others

Specialty generics drugs, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Inflamatory conditions
  • Multiple sclerosis
  • Hepatitis C
  • Others

Speciality generics drugs, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Specialty pharmacy
  • Retail pharmacy
  • Hospital pharmacy

Speciality generics drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Specialty Generics Drugs Market Insights

  • 4.1. Specialty Generics Drugs Market - End-Use Snapshot
  • 4.2. Specialty Generics Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing emphasizing mergers and acquisitions as a means of expanding their presence in the specialty generics market
      • 4.2.1.2. The expiration of patents on specialty drugs to drive the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Low profitability and lack of awareness about these drugs, hinder the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Specialty Generics Drugs Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Specialty Generics Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Injectables
    • 5.3.1. Global Specialty Generics Drugs Market, by Injectables, by Region, 2019-2032 (USD Billion)
  • 5.4. Oral Drugs
    • 5.4.1. Global Specialty Generics Drugs Market, by Oral Drugs, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Specialty Generics Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Specialty Generics Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Specialty Generics Drugs Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 6.4. Inflamatory conditions
    • 6.4.1. Global Specialty Generics Drugs Market, by Inflamatory conditions, by Region, 2019-2032 (USD Billion)
  • 6.5. Multiple sclerosis
    • 6.5.1. Global Specialty Generics Drugs Market, by Multiple sclerosis, by Region, 2019-2032 (USD Billion)
  • 6.6. Hepatitis C
    • 6.6.1. Global Specialty Generics Drugs Market, by Hepatitis C, by Region, 2019-2032 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Specialty Generics Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Specialty Generics Drugs Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3. Specialty pharmacy
    • 7.3.1. Global Specialty Generics Drugs Market, by Specialty pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail pharmacy
    • 7.4.1. Global Specialty Generics Drugs Market, by Retail pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Hospital pharmacy
    • 7.5.1. Global Specialty Generics Drugs Market, by Hospital pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Specialty Generics Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Specialty Generics Drugs Market - North America
    • 8.3.1. North America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Specialty Generics Drugs Market - U.S.
      • 8.3.4.1. U.S.: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Specialty Generics Drugs Market - Canada
      • 8.3.5.1. Canada: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Specialty Generics Drugs Market - Europe
    • 8.4.1. Europe: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Specialty Generics Drugs Market - UK
      • 8.4.4.1. UK: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Specialty Generics Drugs Market - France
      • 8.4.5.1. France: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Specialty Generics Drugs Market - Germany
      • 8.4.6.1. Germany: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Specialty Generics Drugs Market - Italy
      • 8.4.7.1. Italy: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Specialty Generics Drugs Market - Spain
      • 8.4.8.1. Spain: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Specialty Generics Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Specialty Generics Drugs Market - Russia
      • 8.4.10.1. Russia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Specialty Generics Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Specialty Generics Drugs Market - China
      • 8.5.4.1. China: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Specialty Generics Drugs Market - India
      • 8.5.5.1. India: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Specialty Generics Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Specialty Generics Drugs Market - Japan
      • 8.5.7.1. Japan: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Specialty Generics Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Specialty Generics Drugs Market - South Korea
      • 8.5.9.1. South Korea: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Specialty Generics Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Specialty Generics Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Specialty Generics Drugs Market - UAE
      • 8.6.5.1. UAE: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Specialty Generics Drugs Market - Israel
      • 8.6.6.1. Israel: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Specialty Generics Drugs Market - South Africa
      • 8.6.7.1. South Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Specialty Generics Drugs Market - Latin America
    • 8.7.1. Latin America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Specialty Generics Drugs Market - Mexico
      • 8.7.4.1. Mexico: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Specialty Generics Drugs Market - Brazil
      • 8.7.5.1. Brazil: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Specialty Generics Drugs Market - Argentina
      • 8.7.6.1. Argentina: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Apotex Corp.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dr. Reddy's Laboratories Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Endo Pharmaceuticals Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fresenius Kabi Brasil Ltda
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hikma Pharmaceuticals PLC
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG (Sandoz International GmbH)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. STADA Arzneimittel AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10.Sun Pharmaceutical Industries Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Teva Pharmaceuticals Industries Ltd
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Viatris Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables

  • Table 1 Global Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Specialty Generics Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Specialty Generics Drugs Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Specialty Generics Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Specialty Generics Drugs Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 12. Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Specialty Generics Drugs Market